Categories: News

uniQure to Participate in Multiple Upcoming Industry Conferences in October

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LEXINGTON, Mass. and AMSTERDAM, Sept. 30, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming investor and scientific conferences:

  • Chardan’s 5th Annual Genetic Medicines Conference, October 4 – 5, 2021
    • Members of uniQure’s management team, including Matt Kapusta, chief executive officer, will participate in virtual one-on-one investor meetings the morning of Tuesday, October 5th.
    • A fireside chat with Matt Kapusta will take place the same day from 8:00 to 8:30 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.
  • Alliance for Regenerative Medicine: Cell & Gene Meeting on the Mesa, October 12 – 14, 2021
    • Joshua Leeman, Ph.D., VP, Search & Evaluation, Business Development, will be making a corporate presentation on Wednesday, October 13th at 12:15 p.m. PDT.
    • Dr. Leeman will also be participating in a panel entitled, “Delivering the Innovation of Gene Therapy to Patients Through Strategic Collaborations Workshop” on Thursday, October 14th starting at 7:15 a.m. PDT.
  • European Society of Gene and Cell Therapy (ESGCT), October 19 – 22. 2021
    • uniQure will present multiple preclinical data presentations at the meeting. Specific details to follow when the meeting abstracts are released.
  • Jefferies Gene Therapy/Editing Summit, October 27 – 28, 2021
    • Members of uniQure’s management team including Ricardo Dolmetsch, Ph.D., president of Research & Development, will participate virtually in one-on-one investor meetings throughout the day on Thursday, October 28th.
    • A fireside chat with Matt Kapusta will take place the same day from 12:00 to 12:30 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website.

About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with severe genetic diseases of the central nervous system (CNS) and liver, including clinical programs in hemophilia B and Huntington’s disease and preclinical candidates in Fabry disease, spinocerebellar ataxia Type 3, temporal lobe epilepsy, Alzheimer’s, Parkinson’s, and ALS. www.uniQure.com

uniQure Contacts:        
         
FOR INVESTORS:       FOR MEDIA:
         
Maria E. Cantor   Chiara Russo   Tom Malone
Direct: 339-970-7536   Direct: 617-306-9137   Direct: 339-970-7558
m.cantor@uniQure.com   c.russo@uniQure.com   t.malone@uniQure.com

Staff

Recent Posts

Canadian Institute of Actuaries Announces Alicia Rollo as New Executive Director

Ottawa, Ontario--(Newsfile Corp. - June 26, 2025) - As the Canadian Institute of Actuaries (CIA)…

51 minutes ago

Jennifer Hayes Joins Porter to Elevate National Nursing Operations

PORTER WELCOMES A SEASONED LEADER TO ADVANCE MEMBER EXPERIENCE NATIONWIDE BALTIMORE, June 26, 2025 /PRNewswire/…

51 minutes ago

Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety

Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved…

51 minutes ago

Invetech and AiCella Announce Strategic Collaboration to Advance Cell Therapy Innovation

SAN DIEGO, June 26, 2025 /PRNewswire/ -- Invetech, a global leader in solving complex manufacturing…

51 minutes ago

Rewriting the Timeline of Detection: Linus Health’s Digital Platform Uncovers the Earliest Signs of Cognitive Decline

New research reveals that subtle response-time biomarkers—captured in minutes via digital assessments—can flag Alzheimer's and…

51 minutes ago

InVita Healthcare Technologies Announces Increasing Adoption of WarrantyTracker at Healthcare Facilities Nationwide

WarrantyTracker takes explant management to the next level -- expanding beyond warranty claims to support…

51 minutes ago